Literature DB >> 14569191

Self-reported family history of cancer: the utility of probing questions.

Nina S Kadan-Lottick1, Debra L Friedman, Ann C Mertens, John A Whitton, Yutaka Yasui, Louise C Strong, Leslie L Robison.   

Abstract

BACKGROUND: Many studies of familial aggregation of cancer have relied on self-reported cancer family history data because verification through medical records was not feasible. Self-reported data might be nonspecific and prone to errors, although of high quality for certain cancers. We evaluated the utility of a brief follow-up survey to elicit further details regarding uncertain cancer conditions.
METHODS: We reviewed all of the cancer family histories reported by 13,972 survivors participating in the Childhood Cancer Survivor Study. There were 533 affected relatives (obtained from 500 cases) identified as having uncertain cancer histories. Of these 500 cases, 386 (77%) were successfully recontacted. They completed a 5- to 7-minute telephone survey containing focused, probing questions regarding their 406 relatives with uncertain cancer conditions. Two investigators independently reviewed the survey responses.
RESULTS: A disease site and malignancy status could be determined for 81% (331 of 406) of the relatives. Among the 312 relatives with a single uncertain cancer condition, the additional survey identified 58% as having a malignant condition with a known primary site, 7% as having a malignant condition with an undetermined primary site, 22% as having a benign condition, and 13% for whom no further clarification was possible. Among the 94 relatives with multiple reported cancers, 64% were found to represent a single diagnosis.
CONCLUSIONS: Incorporation of additional probing questions into the initial family history interview would improve the ability to classify cancer reports by site and malignancy status. The utility of these additional questions could vary by the site and specificity of the initial cancer reports.

Entities:  

Mesh:

Year:  2003        PMID: 14569191     DOI: 10.1097/01.ede.0000091602.06231.aa

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.860


  4 in total

1.  Validity of self reported diagnoses of cancer in a major Spanish prospective cohort study.

Authors:  C Navarro; M D Chirlaque; M J Tormo; D Pérez-Flores; M Rodríguez-Barranco; A Sánchez-Villegas; A Agudo; G Pera; P Amiano; M Dorronsoro; N Larrañaga; J R Quirós; E Ardanaz; A Barricarte; C Martínez; M J Sánchez; A Berenguer; C A González
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

2.  Family history of cancer and risk of pediatric and adolescent Hodgkin lymphoma: A Children's Oncology Group study.

Authors:  Amy M Linabery; Erik B Erhardt; Michaela R Richardson; Richard F Ambinder; Debra L Friedman; Sally L Glaser; Alain Monnereau; Logan G Spector; Julie A Ross; Seymour Grufferman
Journal:  Int J Cancer       Date:  2015-05-19       Impact factor: 7.396

Review 3.  The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research.

Authors:  Leslie L Robison; Gregory T Armstrong; John D Boice; Eric J Chow; Stella M Davies; Sarah S Donaldson; Daniel M Green; Sue Hammond; Anna T Meadows; Ann C Mertens; John J Mulvihill; Paul C Nathan; Joseph P Neglia; Roger J Packer; Preetha Rajaraman; Charles A Sklar; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

4.  An internal performance assessment of CancerGene Connect: an electronic tool to streamline, measure and improve the genetic counseling process.

Authors:  Mary Pritzlaff; Arielle Yorczyk; Linda S Robinson; Sara Pirzadeh-Miller; Tirun Lin; David Euhus; Theodora S Ross
Journal:  J Genet Couns       Date:  2014-06-12       Impact factor: 2.537

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.